Clinical Case Discussion Platforms Compared

MedShr and Figure 1 center case sharing and discussion across broad healthcare-professional communities. Sermo combines a physician community with case discussion, drug ratings, news, and paid research opportunities. Docquity combines a verified-doctor network, clinical discussions, and continuing education with a strong Southeast Asian focus. SameCase is an early-stage, two-sided network focused on finding similar narratives, public constructed teaching examples, protected clinician case workflows, and patient or caregiver preparation.

That summary does not name a winner. The right choice depends on who needs access, whether the task is discussion or retrieval, where participants are licensed, what kind of media is involved, whether continuing-education credit matters, and what governance the case requires. This comparison was checked against each platform’s own public pages on 30 August 2026. Those pages are interested sources describing their products, so feature availability, eligibility, pricing, and policies should be verified directly before use.

Start with audience. “For healthcare professionals” can include different combinations of doctors, nurses, allied professionals, dentists, and students, while a physician-only community has a narrower peer set. Then inspect geography and verification. A large global network may still have uneven participation in a particular specialty, language, or jurisdiction, and a verified badge can mean different evidence was checked.

Next compare the case workflow, discovery model, privacy process, and business model. A feed is useful for serendipitous learning; structured search or similarity retrieval is better when starting with a particular presentation. Media-heavy cases need consent and image-scrubbing controls. Free membership can coexist with advertising, sponsored education, research recruitment, surveys, or enterprise services. Those models are not automatically improper, but they affect what appears in the product and should be understood.

• Audience and verification: who can read, post, comment, or answer—and how is status checked?
• Case workflow: text, images, video, structured fields, consent, de-identification, and moderation.
• Discovery: chronological feed, specialty browsing, keyword search, similarity retrieval, or expert routing.
• Geography and language: where registration checks, communities, and educational programs are strongest.
• Commercial model: membership, sponsorship, surveys, education, recruiting, data products, or enterprise services.
• Control: editing, export, deletion, retention, reuse, research use, and response to a privacy report.

MedShr describes itself as a case-discussion platform for verified health professionals, including doctors, medical students, dentists, nurses, pharmacists, and physiotherapists. Its public pages emphasize clinical images and video, case following, private or wider-community sharing, an in-app patient-consent process, and both informal and accredited case-based learning. It is available on the web and mobile devices.

This makes MedShr a plausible fit when the main task is sharing and discussing a media-rich case with a broad professional community or using structured learning modules. Before posting, verify the current eligibility route in your jurisdiction, the consent method required for the specific case, image and metadata handling, who can access a selected group, and how deletion or export works. The platform’s membership and case-volume figures are self-reported and should not be treated as audited measures of clinical quality.

Figure 1 describes a verified healthcare-professional community organized around real patient cases, discussion, medical images, specialty resources, and continuing learning. Its public material emphasizes a global case library, real-time peer collaboration, and discovery through a feed and specialty resources. The eligible audience is broader than physicians alone.

Figure 1 may suit clinicians who want image-led cases, broad international exposure, and ongoing feed-based learning. Check the current verification categories, whether a particular case is visible beyond the intended group, consent and de-identification requirements, moderation, and the treatment of uploaded media. Figure 1 cites member data and case counts on its own site; those statements describe its position but are not independent comparisons with another platform.

Sermo describes a verified physician community that supports pseudonymous or profile-based discussion, challenging patient cases, medical news, virtual events, drug ratings, and paid survey participation. Its scope is therefore wider than case retrieval or teaching alone. The narrower physician focus may be useful when the desired peer group is specifically doctors rather than the broader healthcare workforce.

Sermo may fit physicians who want case discussion inside a wider professional social and research environment. Evaluate how posts are segmented, which activities are sponsored or paid, what profile and contribution data may be used for research or client services, and what controls apply to a clinical case. Its public membership and drug-rating totals are company-reported marketing figures, not evidence that a particular specialty question will receive a useful response.

Docquity describes a network for verified doctors, with clinical case discussion, medical literature search, expert content, webinars, and continuing professional-development or medical-education opportunities. Its public site emphasizes communities in Southeast Asian markets and verification through medical societies and associations. It also states that it works with hospitals, medical associations, and pharmaceutical companies.

Docquity may fit doctors whose priority is regional peer connection and continuing education alongside case discussion. Confirm whether registration is supported in your country, which courses carry locally recognized credit, how sponsored material is labeled, and how case content may be processed or reused. Regional strength can be an advantage when practice context matters, but public user totals do not establish coverage for every country, specialty, or language.

SameCase is designed around a different starting question: “What solved or teaching cases have a meaningfully similar presentation?” Public constructed examples show reasoning patterns, while verified doctors can contribute de-identified cases and use protected matching tools. Patients and caregivers have a separate educational path for organizing a symptom story and preparing questions; they do not enter the verified clinical discussion layer as doctors.

SameCase may fit users who value symptom-pattern retrieval, explicit separation between public teaching material and protected case workflows, and a bridge from patient preparation to clinician-led interpretation. Its central limitation is maturity: it is an early-stage network, and useful matching depends on corpus coverage. An absent match is not evidence against a diagnosis, and a high-ranked match is not a probability. The public teaching examples are constructed scenarios, not prevalence data or real patient records.

Shortlist two platforms and test them with the same de-identified, non-sensitive teaching problem before moving a real case. Compare the relevance of results, the quality and timeliness of discussion, the clarity of why content was surfaced, and the ease of correcting or removing material. Do not use a rare real case as a product trial; start with a synthetic or already-public scenario approved for the purpose.

• Choose MedShr when broad professional case discussion, clinical media, and learning modules are central—and its current privacy workflow fits your institution.
• Choose Figure 1 when a global healthcare-professional case feed and image-led learning are the primary draw.
• Choose Sermo when physician-only networking, case discussion, drug ratings, and optional research participation belong in one community.
• Choose Docquity when verified-doctor networking and continuing education in its supported Asian markets are priorities.
• Choose SameCase when the main job is narrative similarity retrieval and clearly separated doctor, patient-preparation, and constructed-teaching paths—and an early corpus meets the use case.
• Use more than one when the tasks differ; a feed, a literature database, and a similarity tool solve different retrieval problems.

No platform label makes a case safe to share. Confirm the lawful basis, consent or authorization, institutional rules, de-identification method, intended audience, data location, retention, deletion, breach response, and whether screenshots or downloads can leave the platform. HHS guidance identifies Safe Harbor and Expert Determination as two HIPAA de-identification methods in the United States and notes that residual risk is not zero; other jurisdictions have different legal tests.

Also ask how the platform distinguishes peer discussion, educational content, sponsored material, generated summaries, and individualized medical advice. A verification process can improve accountability but does not validate every post. A large community can widen recall but does not make anecdotes representative. Case discussion should lead to questions and independently supported reasoning, not copied management.

This page uses current public product descriptions and policies as evidence of what each company says it offers. It does not independently audit security architecture, member identity, active-user counts, case quality, response times, clinical outcomes, regulatory compliance, or deletion behavior. Features and access terms can change after the checked date. Readers should inspect current policies, test the relevant workflow, and involve privacy, legal, security, or clinical-governance teams where required.

SameCase is the publisher of this comparison and is therefore an interested source about itself. The page avoids a winner score, uses the same decision dimensions for every service, names SameCase’s early-stage limitation, and links directly to each competitor’s public description. Corrections should be sent through the SameCase contact page with a source and effective date.